Drug: NAPROSYN Injury: Musculoskeletal stiffness Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 115950735 | NAPROSYN | Musculoskeletal stiffness | AMGEN | 33.00 YR | F | 0 | 20160715 | CA |
| 117015188 | NAPROSYN | Musculoskeletal stiffness | PFIZER | 33.00 YR | F | 0 | 20160729 | CA |
| 123270183 | NAPROSYN | Musculoskeletal stiffness | AMGEN | 51.00 YR | M | 0 | 20160827 | CA |
| 950323610 | NAPROSYN | Musculoskeletal stiffness | ROCHE | 52.52 YR | F | 69 KG | 20160714 | CA |
| 968487813 | NAPROSYN | Musculoskeletal stiffness | ROCHE | 48.54 YR | F | 116 KG | 20160822 | CA |
| 1123118011 | NAPROSYN | Musculoskeletal stiffness | PFIZER | 50.00 YR | M | 63 KG | 20160830 | CA |
Total Records: 6 Number of Pages: 1